Diagnostics Biochem Canada Inc.

Published purpose

Global Automated Immunoassay Analyzers market is valued at USD 11.53 Billion in 2022 and is projected to attain a value of USD 35.99 Billion by 2030 at a CAGR of 15.30% during the forecast period, 2022–2028 (https://www.vantagemarketresearch.com/industry-report/automated-immunoassay-analyzers-market-1314).. Automated analyzers are one of the main diagnostic platforms in Canada and other developed nations. In line with this market trend, DBC will transfer vital diagnostic hormone assays, a field in which it is a global market leader, from a microplate-based platform to higher throughput automated systems. This initiative will expand the addressable market both locally and globally for DBC products providing sustained double-digit growth well into the future.